Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1991-01-16
1992-08-04
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424440, 424468, 424469, 424470, 424488, 424499, 424500, 514960, 514965, A61K 916, A61K 922
Patent
active
051357577
ABSTRACT:
A free-flowing directly compressible granulation useful as a slow release pharmaceutical excipient is disclosed. The excipient includes a hydrodrophilic matrix which includes heteropolysaccharide and a polysaccharide material capable of cross-linking the heteropolysaccharide, and an inert diluent.
REFERENCES:
patent: 2993836 (1961-07-01), Nash et al.
patent: 3074852 (1963-01-01), Mayron
patent: 3079303 (1963-02-01), Raff et al.
patent: 3133863 (1964-05-01), Tansey
patent: 3147187 (1964-09-01), Playfair
patent: 3388041 (1968-06-01), Gans et al.
patent: 3456049 (1969-07-01), Hotko et al.
patent: 3627583 (1971-12-01), Troy et al.
patent: 3629393 (1971-12-01), Nakamoto
patent: 3639169 (1971-12-01), Broeg et al.
patent: 3726690 (1973-04-01), Schuppner, Jr.
patent: 3728445 (1973-11-01), Bardani
patent: 3773920 (1973-11-01), Nakamoto et al.
patent: 3836618 (1974-09-01), Stevens
patent: 3864469 (1975-02-01), Reiser et al.
patent: 3950508 (1976-04-01), Mony et al.
patent: 3963832 (1976-06-01), Hashimoto et al.
patent: 4013820 (1977-03-01), Farhadieh et al.
patent: 4072535 (1977-08-01), Short et al.
patent: 4167558 (1979-09-01), Sheth et al.
patent: 4199560 (1980-04-01), Gyarmati
patent: 4259314 (1981-03-01), Lowey
patent: 4308251 (1981-12-01), Dunn et al.
patent: 4361545 (1982-11-01), Powell et al.
patent: 4389393 (1983-10-01), Schor et al.
patent: 4424235 (1984-01-01), Sheth et al.
patent: 4439453 (1984-06-01), Vogel
patent: 4525345 (1985-06-01), Dunn et al.
patent: 4542011 (1985-09-01), Gleixner
patent: 4556678 (1985-12-01), Hsiao
patent: 4590062 (1986-05-01), Jang
patent: 4623394 (1986-11-01), Nakamura et al.
patent: 4692337 (1987-09-01), Ukigaya et al.
patent: 4695463 (1987-09-01), Yang et al.
patent: 4695467 (1987-09-01), Uemura et al.
patent: 4698101 (1987-10-01), Koivurinta
patent: 4698264 (1987-10-01), Steinke
patent: 4704285 (1987-11-01), Alderman
patent: 4717713 (1988-01-01), Zatz et al.
patent: 4755389 (1988-01-01), Jones et al.
patent: 4762702 (1988-08-01), Gergely et al.
patent: 4792452 (1988-12-01), Howard
patent: 4803077 (1989-02-01), Mitsuhashi et al.
patent: 4828836 (1989-05-01), Elger
patent: 4829056 (1989-05-01), Sugden
patent: 4855143 (1989-08-01), Lowey
Satiaxane Food-Grade Xanthan Gum published by Satia.
Hydrocolloids a publication by Mero Rousselot Satia.
Xanthan Gum/Keltrol Kelzan a Natural Biopolysaccharide for Scientific Water Control.
Formulating for Controlled Release with Methocel Cellulose Ethers, the Dow Chemical Company, 1987.
H. M. Ingani et al., 6th Pharmaceutical Technology Conference, vol. II, pp. 459-460, Canterbury, England 1987.
Baichwal Anand R.
Staniforth John N.
Edward Mendell Co. Inc.
Page Thurman K.
Spear James M.
LandOfFree
Compressible sustained release solid dosage forms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compressible sustained release solid dosage forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compressible sustained release solid dosage forms will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-776955